128 related articles for article (PubMed ID: 20611009)
21. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
22. [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
Raizer G; Igaz P; Pregun I; Dabasi G; Rácz K
Orv Hetil; 2011 Mar; 152(10):407-10. PubMed ID: 21354958
[TBL] [Abstract][Full Text] [Related]
23. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
[TBL] [Abstract][Full Text] [Related]
24. Carcinoid of the pancreas.
Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
[TBL] [Abstract][Full Text] [Related]
25. In-111 labeled octreotide imaging of a primary carcinoid lesion undetected by conventional imaging studies in a patient with "chronic pancreatitis".
Kummar S; Kim SL; Halkar RK; Galt JR
Clin Nucl Med; 1996 Aug; 21(8):634-7. PubMed ID: 8853917
[TBL] [Abstract][Full Text] [Related]
26. [Effective treatment of a hormonally inactive carcinoid tumour with somatostatin analogues: application of serum chromogranin-A for clinical follow-up].
Igaz P; Rácz K; Tulassay Z
Orv Hetil; 2007 Dec; 148(49):2343-6. PubMed ID: 18048114
[TBL] [Abstract][Full Text] [Related]
27. Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors.
Moattari AR; Deftos LJ; Vinik AI
J Clin Endocrinol Metab; 1989 Oct; 69(4):902-5. PubMed ID: 2778040
[TBL] [Abstract][Full Text] [Related]
28. Treatment of metastatic carcinoid tumours with octreotide.
Ozbey N
Int J Clin Pract; 2002 Jun; 56(5):407. PubMed ID: 12137455
[No Abstract] [Full Text] [Related]
29. Gastric carcinoid type I tumour: new diagnostic and therapeutic method.
Prommegger R; Bale R; Ensinger C; Sauper T; Profanter C; Knoflach M; Moncayo R
Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):705-7. PubMed ID: 12840685
[No Abstract] [Full Text] [Related]
30. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis.
Solcia E; Rindi G; Fiocca R; Villani L; Buffa R; Ambrosiani L; Capella C
Yale J Biol Med; 1992; 65(6):793-804; discussion 827-9. PubMed ID: 1341079
[TBL] [Abstract][Full Text] [Related]
31. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
Dakin GF; Warner RR; Pomp A; Salky B; Inabnet WB
J Surg Oncol; 2006 Apr; 93(5):368-72. PubMed ID: 16550587
[TBL] [Abstract][Full Text] [Related]
32. Carcinoid tumors of the stomach: a clinical and radiographic study.
Binstock AJ; Johnson CD; Stephens DH; Lloyd RV; Fletcher JG
AJR Am J Roentgenol; 2001 Apr; 176(4):947-51. PubMed ID: 11264084
[TBL] [Abstract][Full Text] [Related]
33. Commentary: a gastrin antagonist against carcinoids--implications for PPI-induced hypergastrinaemia.
McCarthy DM
Aliment Pharmacol Ther; 2013 Jan; 37(2):276-7. PubMed ID: 23252778
[No Abstract] [Full Text] [Related]
34. Partial remission of carcinoid tumor in response to cyproheptadine.
Leitner SP; Greenberg P; Danieu LA; Michaelson RA
Ann Intern Med; 1989 Nov; 111(9):760-1. PubMed ID: 2478062
[No Abstract] [Full Text] [Related]
35. Octreotide exerts only acute, but no sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome.
Zomerhuis MT; Hussain SM; Feelders RA; van der Lely AJ; de Herder WW
Neuroendocrinology; 2005; 82(1):41-8. PubMed ID: 16391492
[TBL] [Abstract][Full Text] [Related]
36. Carcinoid tumours of the gastrointestinal tract.
Ihász M; Balázs M; Csillag A; Szabó K; Horkai F
Acta Chir Acad Sci Hung; 1982; 23(2):95-115. PubMed ID: 6762790
[No Abstract] [Full Text] [Related]
37. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.
Siu LL; Chapman W; Moore MJ
Am J Clin Oncol; 1997 Dec; 20(6):558-61. PubMed ID: 9391539
[TBL] [Abstract][Full Text] [Related]
38. Carcinoid syndrome caused by a serotonin-secreting pituitary tumour.
Lynggård LA; Nielsen EH; Laurberg P
Eur J Endocrinol; 2014 Feb; 170(2):K5-9. PubMed ID: 24174286
[TBL] [Abstract][Full Text] [Related]
39. [A voluminous hepatic pseudocyst: metastasis of a carcinoid tumor of the ileum].
Bremer A; De Graef J; Duret R; Heimann R; Chaikh A; Rutsaert J
Acta Gastroenterol Belg; 1986; 49(5):517-24. PubMed ID: 3604558
[No Abstract] [Full Text] [Related]
40. Mesenteric paraganglioma: the case of mistaken identity.
Pirpiris A; Fu M; Budge J; Putnis S
ANZ J Surg; 2017 Apr; 87(4):312-313. PubMed ID: 25366582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
